<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01757379</url>
  </required_header>
  <id_info>
    <org_study_id>ML5768</org_study_id>
    <nct_id>NCT01757379</nct_id>
  </id_info>
  <brief_title>Determination of the Bioavailability of Short Chain Fatty Acids in Healthy Humans</brief_title>
  <official_title>Evaluation of the Bioavailability and Production of Short Chain Fatty Acids in the Colon. A Stable Isotope Study in Healthy Humans.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Katholieke Universiteit Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Katholieke Universiteit Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the bioavailability of acetate, propionate and
      butyrate in healthy humans using a stable isotope technology.

      In addition the level of acetate, propionate and butyrate production from inulin will be
      determined using the principle of isotope dilution.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Concentrations of the short chain fatty acids (acetate, propionate and butyrate) in plasma and urine samples</measure>
    <time_frame>12 hours each test day and 4 test days/volunteer</time_frame>
    <description>Participants performed each 4 test days and they were followed each test day for 12 hours, with sample collections at regular time points. Blood samples were collected every hour during the first 4 hours and afterwards every 20 minutes during 8 hours. Urine samples were collected during 24h in different fractions: 0-4h, 4-8h, 8-12h, 12-24h.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Short Chain Fatty Acids Bioavailability</condition>
  <arm_group>
    <arm_group_label>13C-labeled acetate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>13C-labeled propionate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>13C-labeled butyrate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Inulin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>13C-labeled Acetate</intervention_name>
    <description>400 mg of sodium acetate 1-13C (2 colon delivery capsules with 200 mg)</description>
    <arm_group_label>13C-labeled acetate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>13C-labeled propionate</intervention_name>
    <description>340 mg of sodium propionate 1-13C (2 colon delivery capsules with 170 mg)</description>
    <arm_group_label>13C-labeled propionate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>13C-labeled butyrate</intervention_name>
    <description>990 mg sodium butyrate 1-13C (2 colon delivery capsules with 495 mg)</description>
    <arm_group_label>13C-labeled butyrate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Inulin</intervention_name>
    <description>15 g of inulin dissolved in 200 ml of water</description>
    <arm_group_label>Inulin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers

          -  Regular dietary pattern (3 meals/day)

          -  Age: 18-65y

          -  BMI: 18,5-27 kg/m2

        Exclusion Criteria:

          -  Intake of antibiotics 1 month prior to the study

          -  Abdominal surgery in the past, with the exception of appendectomy

          -  Intake of medication influencing the gastro-intestinal system 14 days prior to the
             study

          -  In treatment at a dietician

          -  Intake of pre- and/or probiotics

          -  Exposure to radioactivity 1 year prior to the study

          -  Serious chronic disease of the gastrointestinal tract

          -  Use of medication that affects the gastro-intestinal tract during the last 2 weeks
             prior to the study

          -  Pregnancy, pregnancy desire or lactation

          -  Blood donation during the last 3 months prior to the study

          -  Diabetes (type 1 or 2)

          -  Aberrant hemoglobin level (Hb) in blood. Normal between 14.0 and 18.0 g/dL for men and
             between 12.0 and 16.0 g/dL for women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristin Verbeke, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>KU Leuven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>KU Leuven/ UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 21, 2012</study_first_submitted>
  <study_first_submitted_qc>December 21, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 28, 2012</study_first_posted>
  <last_update_submitted>January 13, 2015</last_update_submitted>
  <last_update_submitted_qc>January 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Katholieke Universiteit Leuven</investigator_affiliation>
    <investigator_full_name>Kristin Verbeke</investigator_full_name>
    <investigator_title>Professor K. Verbeke</investigator_title>
  </responsible_party>
  <keyword>Short chain fatty acids</keyword>
  <keyword>Acetate</keyword>
  <keyword>Propionate</keyword>
  <keyword>Butyrate</keyword>
  <keyword>Bioavailability</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Butyric Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

